Open versus laparoscopic appendicectomy

M. Kapischke,A. Caliebe,J. Tepel,T. Schulz,J. Hedderich

DOI: https://doi.org/10.1007/s00464-005-0016-x

2006-05-13

Surgical Endoscopy

Abstract:

What problem does this paper attempt to address?

Aspirin Inhibits Fibronectin Expression and Reverses Fibronectin-Mediated Cell Invasiveness by Activating Akt Signaling in Preeclampsia

Mei-Tsz Su,Ching-Wei Tsai,Pei-Yin Tsai,Chia-Yih Wang,Hui-Ling Tsai

DOI: https://doi.org/10.3390/ph15121523

IF: 4.6

2022-12-09

Pharmaceuticals

Abstract:Preeclampsia is a severe gestational hypertensive disorder that may lead to maternal multiple organ dysfunction and adverse fetal outcomes. Aspirin provides a protective effect by reducing the risk of preeclampsia; however, its mechanism of action is unclear. Fibronectin (FN) is a key factor in cell motility and is associated with preeclampsia. Here, we demonstrated that cellular FN expression was elevated in the placenta of preeclamptic patients. The functional roles of plasma and cellular FN in trophoblasts were investigated by treating HTR-8/SVneo cells with exogenous recombinant human FN protein (rhFN) and siRNA, respectively. Trophoblast migration and invasion were inhibited by rhFN and facilitated by FN knockdown. Moreover, rhFN activated ERK and Akt signaling in trophoblasts, and FN-suppressed cell motility was rescued by ERK and/or Akt inhibitors. In this study, aspirin suppressed trophoblast cellular FN expression and reversed FN-mediated cell functions, including cell migration, invasion, and ERK/Akt signal changes. Taken together, the results of this study revealed the effects of FN on trophoblast motility and signaling; aspirin inhibits FN expression and reverses FN-mediated trophoblast biology. These results provide a drug mechanism for disease prevention and a target for preeclampsia intervention.

pharmacology & pharmacy,chemistry, medicinal
Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia.

Mei-Tsz Su,H. Tsai,P. Kuo,P. Tsai,Ting‐Yu Chen,Chia‐Yih Wang

DOI: https://doi.org/10.1097/HJH.0000000000002185

IF: 4.9

2019-12-01

Journal of Hypertension

Abstract:OBJECTIVE Recent studies suggested that prophylactic aspirin prior to 16 weeks of gestation in high-risk patients may reduce the risk of developing preeclampsia; however, the exact mechanism of aspirin's effect on the pathophysiology of preeclampsia is not clear. This study was designed to investigate the effect of aspirin on trophoblast cell function and its effect on soluble fms-like tyrosine kinase 1 (sFlt-1) production to elucidate the preventive mechanisms for preeclampsia. METHODS AND RESULTS We used two human trophoblastic cell lines (HTR-8/SVneo and JAR) and freshly isolated cytotrophoblasts from normal and preeclamptic placenta at term to determine the effect of aspirin on trophoblast cell function. Trophoblasts were pretreated with aspirin, and then cell functions and sFlt-1 expression were assessed. Our results showed that aspirin promoted trophoblast invasion not only in HTR-8/SVneo and JAR cells, but also in isolated cytotrophoblasts. sFlt-1 production was repressed by aspirin in a dose-dependent manner. By adding Flt-1 recombinant protein, the trophoblast invasion ability was inhibited in HTR-8/SVneo cells, which was reversed by Flt-1 small interfering ribonucleic acid knockdown. In addition, metalloproteinase 2/9 expression and activity were activated by aspirin but inhibited by sFlt-1. Aspirin also downregulated Akt phosphorylation, and trophoblast invasiveness was facilitated under Akt inhibitor treatment. CONCLUSION Aspirin enhances cell invasiveness and inhibits sFlt-1 production in trophoblasts. Moreover, sFlt-1 itself also inhibits trophoblast invasion. Our novel findings suggest that the preeclampsia prevention effect of aspirin may be exerted through these two mechanisms.

Medicine
Aspirin reduces sFlt-1 mediated apoptosis of trophoblast cells in preeclampsia.

Tianjun Wang,Shiyun Huang,Z. Ge,Min Zhang,Yetao Xu,Y. Zou,Qing Zuo,Ziyan Jiang,Tingting Zhang

DOI: https://doi.org/10.1093/molehr/gaaa089

2021-01-25

Molecular Human Reproduction

Abstract:Preeclampsia（PE）is a hypertensive disorder that occurs during pregnancy. Low-dose aspirin is used to reduce the occurrence of early-onset preeclampsia, however, the mechanisms are not clear. The aim of this study was to to reveal the underlying mechanism of aspirin in reducing sFlt-1 mediated apoptosis of trophoblast cells in preeclampsia. Serum sFlt-1 and sEng profiles and placental oxidative stresslevels were significantly decreased in preeclampsia patients treated with aspirin compared with untreated patients without it, while serum PLGF and placental SOD profiles were increased in preeclampsia patients with aspirin. Aspirin attenuated the role of sFlt-1 in oxidative stress and endothelial dysfunction and reduced apoptosis of trophoblasts by inactivating the NF-κB signaling pathway in HTR-8/SVneo trophoblast cells. Blood pressure, urine protein, swelling of the villous vessels and mitochondrial parameters were noted to be much better after aspirin administrated to sFlt-1 treated pregnant mice. In conclusion, aspirin reverses the endothelial dysfunction and oxidative stress caused by sFlt-1 and thus reduces apoptosis of preeclamptic trophoblasts by inactivating NF-κB signaling pathway.

Medicine
A conservative orthodontic-prosthetic approach for a difficult clinical situation: a case report.

E. Gazit,Y. Ausker,M. Lieberman

Abstract:The accidental loss of maxillary teeth, without replacement, led to an overeruption of the opposing mandibular teeth. The resulting reduction of interarch space created a severe prosthetic problem that was resolved by orthodontic management.
The Intervention Effect of Aspirin on a Lipopolysaccharide-Induced Preeclampsia-Like Mouse Model by Inhibiting the Nuclear Factor-Κb Pathway†

Guanlin Li,Liyang Ma,Li Lin,Yan-ling Wang,Huixia Yang

DOI: https://doi.org/10.1093/biolre/ioy025

2018-01-01

Biology of Reproduction

Abstract:Abstract Preeclampsia is a severe pregnancy-related disorder, and patients usually present with high circulating inflammatory factor levels and excessive activation of the nuclear factor-κB (NF-κB) pathway. Administration of aspirin (ASP) is effective for preventing preeclampsia, and thus, we propose that ASP might affect placental function by regulating the NF-κB pathway. Systemic lipopolysaccharide (LPS) (20 µg/kg) was used to induce preeclampsia-like pregnant mouse model, and low-dose ASP (15.2mg/kg) was administrated. Here, we report significantly increased circulatory expression levels of the proinflammatory cytokines tumor necrosis factor-alpha, interleukin-6, and soluble Fms-related tyrosine kinase-1 in LPS-treated pregnant mice, accompanied by kidney and placental dysfunction. Low-dose ASP treatment significantly reversed the preeclampsia-like phenotype, lowering hypertension, decreasing proteinuria, and ameliorating fetal growth retardation. Moreover, the excessive activation of NF-κB signaling in mice placentae induced by LPS was significantly reduced by ASP. In JEG-3 cells, LPS activated the NF-κB signaling pathway by upregulating the expression of cyclooxygenase-2 (COX-2) and related inflammatory factors, whereas the invasion ability of JEG-3 cells was weakened. However, ASP administration impeded NF-κB signaling activation, downregulated COX-2 and inflammatory factor expression, and rescued trophoblast invasion. This study provides new evidence that low-dose ASP is beneficial for preeclampsia prevention by inhibiting NF-κB and its downstream signaling pathways in trophoblast cells. Summary Sentence Low-dose ASP is beneficial for preventing LPS-induced preeclampsia by inhibiting NF-κB and downstream signaling pathways in trophoblast cells.
Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rat by inhibiting the pro-inflammatory pathway.

Jieqiong Sun,Huimei Zhang,Fang Liu,Dongmei Tang,Xuhong Lu

DOI: https://doi.org/10.1139/cjpp-2018-0087

2018-01-01

Canadian Journal of Physiology and Pharmacology

Abstract:Preeclampsia is an inflammatory disease and has connection with increased pro-inflammatory cytokines. Aspirin reduces the incidence of preeclampsia complications. However, the effects of aspirin on lipopolysaccharide-induced preeclampsia-like symptoms in rats have not been reported and the underlying molecular mechanism has not been illuminated. Hence, we investigated the anti-inflammatory effects of aspirin on lipopolysaccharide-induced preeclampsia-like phenotypes in pregnant rats and elucidated the potential molecular mechanism. Preeclampsia-like phenotypes were induced by tail vein injection of lipopolysaccharide (1 mu g/kg) on gestational day 14. Aspirin (2 mg/kg per day) were administered from gestational day 14 to 19. Clinical phenotypes were recorded. Placenta tissues and serum were obtained to measure inflammatory cytokines levels using ELISA kit on gestational day 20. The mRNA expressions of IL-6, IL-1 beta, and MCP-1 were measured by real-time PCR. Protein expressions including TLR4, MyD88, NF-kappa Bp65, and TLR2 were determined by Western blot analysis in the rat placentas of each group. Aspirin obviously assuaged lipopolysaccharide-induced preeclampsia-like phenotypes in pregnant rats. Aspirin treatment significantly decreased the levels of pro-inflammatory cytokines in serum and placenta tissues of preeclampsia rats. Aspirin also obviously downregulated the mRNA expressions of IL-6, IL-1 beta, and MCP-1 and assuaged the activation of TLR4, MyD88, NF-kappa Bp65, and TLR2 in the placental tissue. Our results indicated that aspirin could assuage preeclampsia-like phenotypes, and this improvement effect is possibly the result of the suppression of pro-inflammatory cytokines via the TLR4, MyD88, NF-kappa Bp65, and TLR2 signaling pathway.
An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts

Jiawu Zhao,Rui Duan,Jinghui Sun,Rebecca P. Chow,Timothy J. Lyons,Jeremy Y. Yu

DOI: https://doi.org/10.3390/cells13020113

IF: 6

2024-01-06

Cells

Abstract:Low-dose aspirin (LDA) is efficacious in preventing preeclampsia, but its mechanism of action is unclear. Conflicting evidence suggests that it may inhibit placental trophoblast release of soluble fms-like tyrosine kinase-1 (sFlt1), a key mediator of preeclampsia. We examined whether, and at what concentrations, aspirin and its principal metabolite, salicylic acid, modulate sFlt1 release and/or expression in trophoblasts. Human trophoblast lines BeWo and HTR-8/SVneo were cultured; BeWo cells were also treated with 1% oxygen vs. normoxia to mimic hypoxia in preeclamptic placentas. Cells were treated with aspirin or salicylic acid vs. vehicle for 24 h at concentrations relevant to LDA and at higher concentrations. Protein concentrations (ELISA) and mRNA expression (RT-PCR) of sFlt1 were determined. Under normoxia, LDA-relevant concentrations of aspirin (10–50 μmol/L) or salicylic acid (20–100 μmol/L) had no significant effect on sFlt1 protein release or mRNA expression in BeWo cells. However, inhibition was observed at higher concentrations (1 mmol/L for aspirin and ≥200 μmol/L for salicylic acid). Hypoxia enhanced sFlt1 protein release and mRNA expression in BeWo cells, but these responses were not significantly affected by either aspirin or salicylic acid at LDA concentrations. Similarly, neither drug altered sFlt1 protein secretion or mRNA expression in normoxic HTR-8/SVneo cells at LDA concentrations. We suggest that direct modulation of trophoblast release or expression of sFlt1 is unlikely to be a mechanism underlying the clinical efficacy of LDA in preeclampsia.

cell biology
Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues.

Chang-Shin Park,R. Park,Gopal Krishna

DOI: https://doi.org/10.1016/0024-3205(96)00287-1

1996-06-14

Life Science

Abstract:
Combined apocyanin and aspirin treatment activates the PI3K/Nrf2/HO-1 signaling pathway and ameliorates preeclampsia symptoms in rats

Yaru Ju,Yan Feng,Xiaolin Hou,Lixia Wu,Huixia Yang,Hongjuan Zhang,Yan'Na Ma

DOI: https://doi.org/10.1080/10641955.2021.2014518

Abstract:Objective: Pre-eclampsia (PE) is a pregnancy-associated disease characterized by placental dysfunction and increased oxidative stress. Apocyanin is a potent antioxidant and anti-inflammatory which has shown beneficial effects on PE pathogenesis. Aspirin is recognized as the recommendable drug in PE prevention and therapy. Therefore, we aimed to investigate the effects of combining apocyanin and aspirin to treat PE on rat models induced by N-nitro-L-arginine methyl ester (L-NAME) from gestational day (GD) 6 to 16 and elucidate the potential mechanisms. Methods: First, female pregnant rats were divided into five different groups: pregnant control, PE, PE + apocyanin, PE + aspirin, and PE + apocyanin + aspirin. Animals received apocyanin (16 mg/kg/day) orally or aspirin by gavage (1.5 mg/kg BM/day) from GD 4 to 16. Blood pressure and urine protein content were monitored every 4 days. Results: In the PE rat model, elevated systolic blood pressure and proteinuria were ameliorated by the combination of apocyanin and aspirin. Meanwhile, compared with single-dose apocyanin or aspirin, the combined treatment significantly corrected abnormal pregnancy outcomes, decreased sFlt-1 and PlGF, and alleviated oxidative stress both in blood and placental tissues. Moreover, the combined treatment upregulated PI3K, Akt, Nrf2, and HO-1 protein levels in the placental tissues from PE rats. Conclusion: Overall, our results suggested that combined treatment of apocyanin and aspirin ameliorates the PE symptoms compared with single-dose apocyanin or aspirin in a PE rat model. Also, we demonstrated that activating the PI3K/Nrf2/HO-1 pathway can be a valuable therapeutic target to improve the pregnancy outcomes of PE.
Protective Effects of Aspirin Supplemented With Quercetin in L-NAME-Induced Preeclampsia-Like Rats

J Ding,S Yang,D Chen,X Shi,Y Zhang,L Song,J Zhang

DOI: https://doi.org/10.33549/physiolres.935196

2024-03-06

Physiological Research

Abstract:Aspirin supplemented with quercetin was reported to enhance the therapeutic effects of aspirin in a rat model of preeclampsia. In this study, the underlying mechanisms were further explored. Preeclampsia was induced by L-NAME (50 mg/kg/day) via oral gavage from gestation day (GD)14 to GD19. Aspirin (1.5 mg/kg/day) administration was performed using aspirin mixed with rodent dough from GD0 to GD19. The administration of quercetin (2 mg/kg/day) was performed by intraperitoneal infusion from GD0 to GD19. Protein levels were evaluated using ELISA or Western blot, and microRNA (miRNA) level was evaluated by RT-PCR. Aspirin supplemented with quercetin ameliorated the increase of systolic blood pressure (SBP), proteinuria, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels, and improved the pregnancy outcomes in preeclampsia rats. Aspirin supplemented with quercetin inhibited miR-155 expression in preeclampsia rats. The decreased miR-155 level in placenta further increased the protein level of SOCS1 and inhibited the phosphorylation of p65. In this study, we demonstrated that aspirin supplemented with quercetin enhanced the effects of aspirin for the treatment of preeclampsia.

physiology
Mycoplasma Pulmonis and Lymphoma in Bioassays

G. Krinke

DOI: https://doi.org/10.1177/0300985810374839

2010-11-01

Abstract:Dear sir, I appreciated the contributions published in Veterinary Pathology, September 2009 (vol. 46, no. 5): ‘‘Mycoplasma pulmonis and Lymphoma in Bioassays in Rats,’’ by Schoeb et al (pp. 952–959), as well as ‘‘Confidence in Rodent Carcinogenesis Bioassays,’’ by Ward and Alden (pp. 790–791). They vividly demonstrate how ignorance can produce harm. Let me add, in a few words, my experience in dealing with a similar matter. In 1989, I was employed as a toxicologic pathologist with a major Swiss multinational chemical company. My employer was manufacturing an agrochemical that was appropriately tested for toxicity, registered, and successfully marketed around the world. One day, we received a message that this agrochemical was examined by scientists in a certain country and was found to be carcinogenic to rats. This message was very surprising because our agrochemical had been previously tested in chronic rodent studies in a renowned UK contract research laboratory and was found to be free of carcinogenicity. My employer sent me to visit these scientists and review the available data. My observations and conclusions were as follows:
Vascular Endothelial Growth Factor Attenuates N Omega-Nitro-L-Arginine Methyl Ester-Induced Preeclampsia-Like Manifestations In Rats

Danqing Chen,Hanzhi Wang,Hefeng Huang,Minyue Dong

DOI: https://doi.org/10.1080/10641960802443118

2008-01-01

Clinical and Experimental Hypertension

Abstract:Objectives. To verify the hypothesis that vascular endothelial growth factor (VEGF) attenuates N omega-Nitro-L-arginine Methyl Ester (L-NAME)-induced preeclampsia-like manifestations in rats. Study design. Forty pregnant Wistar rats were randomly divided into four groups: control, preeclampsia model, VEGF treatment, and VEGF prophylactic. On day 5 of gestation, L-NAME was injected subcutaneously in rats of the preeclampsia model, VEGF treatment, and VEGF prophylactic groups. VEGF was given after the occurrence of hypertension and proteinuria in the VEGF treatment group and from day 5 in the VEGF prophylactic group. Blood pressure was monitored and urine protein was assayed. Blood platelet was counted, and serum nitric oxide metabolites, endothelin-1, 6-keto-PGF-1 alpha, and TXB(2) were determined. Results. Blood pressure increased significantly on day 8 of gestation in the preeclampsia model and VEGF treatment groups compared with control (p < 0.05 for both) and remained elevated through the pregnancy in the preeclampsia model group. Blood pressure was significantly decreased after the administration of VEGF in the VEGF treatment group (p < 0.05). There was no significant difference in blood pressure between the VEGF prophylactic group and control (p < 0.05). Urine protein, platelet count, serum nitric oxide metabolites, endothelin-1, 6-keto-PGF-1, and TXB2 were significantly different between control and the preeclampsia model group (p < 0.05), but not between control and the VEGF treatment or VEGF prophylactic groups (p > 0.05 for all). Conclusion. VEGF attenuates L-NAME-induced preeclampsia-like manifestations in rats, suggesting the important role of VEGF in preeclampsia and providing a potential strategy for the prevention and treatment of preeclampsia.
Low-Dose Aspirin Reduces Hypoxia-Induced Sflt1 Release Via The Jnk/Ap-1 Pathway In Human Trophoblast And Endothelial Cells

Li Lin,Guanlin Li,Wanyi Zhang,Yan-Ling Wang,Huixia Yang

DOI: https://doi.org/10.1002/jcp.28533

2019-01-01

Journal of Cellular Physiology

Abstract:Pre-eclampsia (PE) is a serious hypertensive disorder of pregnancy that remains a leading cause of perinatal and maternal morbidity and mortality worldwide. Placental ischemia/hypoxia and the secretion of soluble fms-like tyrosine kinase 1 (sFlt1) into maternal circulation are involved in the pathogenesis of PE. Although low-dose aspirin (LDA) has beneficial effects on the prevention of PE, the exact mechanisms of action of LDA, particularly on placental dysfunction, and sFlt1 release, have not been well investigated. This study aimed to determine whether LDA exists the protective effects on placental trophoblast and endothelial functions and prevents PE-associated sFlt1 release. First, we observed that LDA mitigated hypoxia-induced trophoblast apoptosis, showed positive effects on trophoblast cells migration and invasion activity, and increased the tube-forming activity of human umbilical vein endothelial cells (HUVECs). In addition, LDA decreased hypoxia-induced sFlt1 production, and the c-Jun NH2-terminal kinase/activator protein-1 (JNK/AP-1) pathway was shown to mediate the induction of sFlt1. Moreover, the transcription factor AP-1 was confirmed to regulate the Flt1 gene expression by directly binding to the Flt1 promoter in luciferase assays. The result of chromatin immunoprecipitation assays further demonstrated that LDA could directly decrease the expression of the transcription factor AP-1, and thus decrease sFlt1 production. Finally, the effects of LDA on sFlt1 production were proved in human placental explants. Taken together, our data show the protective effects of LDA against trophoblast and endothelial cell dysfunction and reveal that the LDA-mediated inhibition of sFlt1 via the JNK/AP-1 pathway may be a potential cellular/molecular mechanism for the prevention of PE.
[Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].

P. Rambotti,A. Velardi,F. Spinozzi,B. Falini,M. Martelli

1979-03-31

Abstract:The capacity of peripheral blood lymphocytes from fifteen patients with untreated Hodgkin's disease to form E-rosettes with sheep erytrocytes and to respond to PHA stimulation was found to be impaired in 47% of patients. When peripheral blood lymphocytes were incubated overnight in culture medium containing 20% fetal calf serum, E-RFC levels and the capacity to respond to PHA returned to normal. These functions were resuppressed by additional incubation with Hodgkin's disease serum but not from normal serum. The Hodgkin's disease serum inhibited normal peripheral blood lymphocytes to form E-rosettes and to respond to PHA.
Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Yuying Yan,Huilian Peng,Peng Wang,Hanzhi Wang,Minyue Dong

DOI: https://doi.org/10.1016/j.placenta.2016.01.014

IF: 3.287

2016-01-01

Placenta

Abstract:The aim of this investigation was to determine the expression of fatty acid binding protein 4 (FABP4) in the placenta from women with preeclampsia and normal pregnancy, and to delineate the regulatory effects on thophoblast cell by FABP4. We determined the expression of FABP4 by real-time polymerase chain reaction (PCR) for messenger ribonucleic acid (mRNA) or enzyme-linked immunesorbent assay (ELISA) and Western blotting for protein. Small interference of ribonucleic acid (siRNA) and specific FABP4 inhibitor were used to inhibit FABP4. The proliferation, migration and invasion of trophoblastic cells (Swan-71 and Jar) were evaluated with cell counting kit-8, wound-healing test and transwell analysis respectively. We found the expression of FABP4 was significantly higher in the placenta of preeclamptic women than that of women with normal pregnancy (t = 4.244, P < 0.001 for mRNA; t = 4.536, P < 0.001 for protein). FABP4 siRNA significantly reduced the proliferation of trophoblasts (P < 0.001). The specific inhibition of FABP4 inhibited the proliferation of trophoblasts in a dose-dependent manner (P < 0.001) and the inhibitory effect increased as the concentration of inhibitor increased. FABP4 siRNA and specific inhibitor significantly decreased the migration (P < 0.001) and invasion (P < 0.001) of trophoblasts. We concluded the increase in placental FABP4 expression in preeclampsia may affect the function of trophoblast, and this increase may have a role in the pathogenesis of preeclampsia.
Effect of Vascular Endothelial Growth Factor on Pre-Eclampsia in Pregnant Rats

Dan-Qing Chen,Xiao-Juan Lu,Min-Yue Dong,Zheng-Ping Wang,Jing He

DOI: https://doi.org/10.3785/j.issn.1008-9292.2007.01.014

2007-01-01

Abstract:OBJECTIVE:To investigate relationship between the vascular endothelial growth factor (VEGF) and the pathogenesis of pre-eclampsia in pregnant rats.METHODS:Pregnant rats were divided into two groups randomly. Saline solution or L-nitro arginine methyl ester (L-NAME) 125 mg/d was given subcutaneously from day 7 of gestation till establishing pre-eclampsia. Systolic blood pressure, urine protein, platelet count, and weight of pups and placenta were determined. The levels of VEGF in pregnant rats venous serum, placenta and decidual tissue from normal pregnancy and pre-eclampsia rats were detected by ELISA and immunohistochemistry, respectively.RESULT:Pregnant rats which were given L-NAME produced physical signs similar to those of pre-eclampsia, such as increase in systolic blood pressure [(145.3 +/-4.6)mmHg] and urine protein [(814.3 +/-57.5)mg/L], and decrease in platelet count [(467.1 +/-76.3) x 10(9)/L] and weight of pups and placenta. Compared with controls, the intensity of VEGF immunostaining in trophoblast or decidual cells were significantly reduced. The serum levels of VEGF were significantly lower in pre-eclampsia group than in normal pregnancy.CONCLUSION:Decreased serum levels of VEGF and reduced expression of VEGF in placental tissues might in part explain the pathogenesis of pre-eclampsia in pregnant rats.
Low-dose aspirin prevents LPS-induced preeclampsia-like phenotype via AQP-1 and the MAPK/ERK 1/2 pathway

Jinwen Zhang,Shiwen Jing,Huijuan Zhang,Jun Zhang,Hehui Xie,Liping Feng

DOI: https://doi.org/10.1016/j.placenta.2022.03.007

IF: 3.287

2022-04-01

Placenta

Abstract:IntroductionClinical studies suggest that early pregnancy is the critical window for the prevention of preeclampsia by low-dose aspirin (LDA). Abnormal extravillous trophoblast (EVT) cell invasion and spiral artery (SA) remodeling during early placentation have been observed in preeclampsia cases. Thus, we hypothesized LDA prevents preeclampsia by mitigating EVT migration/invasion and SA remodeling.MethodsA single systemic lipopolysaccharide (LPS) (1 μg/kg) injection was administrated in pregnant mice at e14.5 to induce a preeclampsia-like pregnant mouse model. We administered LDA (2.5 μg/g body weight/day) and observed the effects on LPS-induced preeclampsia-like symptoms by examining the placental histology, protein expression, EVT invasion, and SA remodeling. In human EVT cell line, HTR-8/SVneo, we investigated cell invasion and migration by Matrigel and wound healing assays, respectively. Signaling pathways were surveyed using inhibitors, siRNA transfections, and Western blot.ResultsLDA treatment significantly reversed the preeclampsia-like phenotype induced by LPS, as observed by decreases in hypertension, proteinuria, and fetal growth retardation. The numbers of pathological lesions, including excessive extracellular matrix deposition, endotheliosis, and collapsed glomerular capillaries in kidneys, were sigfinicently lower in the LDA-LPS vs. the LPS group. LDA pretreatment eliminated placental lesions, including calcification, edema, and narrowed uterine spiral arteries and reduced aquaporin 1 (AQP-1) protein expression. In HTR-8/SVneo cells, LDA rescued the decreased cell migration and invation induced by LPS. The phosphorylation of ERK1/2 was up-regulated and AQP-1 expression was decreased by LPS, which were reversed by LDA treatments. The effects of LDA were inhibited when AQP-1 expression was downregulated by siRNA transfection.DiscussionThis study provides new evidence that supports the use of LDA for the prevention of preeclampsia and suggests that the effects of LDA are mediated through a novel mechanism of a water channel, AQP-1, and MAPK signaling.

obstetrics & gynecology,reproductive biology,developmental biology
Aspirin increases estrogen levels in the placenta to prevent preeclampsia by regulating placental metabolism and transport function

Shengbo Huang,Yuan Xu,Yuanqing Guo,Yuanjin Zhang,Yu Tang,Chenmeizi Liang,Liangcai Gao,Bingyi Yao,Xin Wang

DOI: https://doi.org/10.1016/j.bcp.2024.116561

2024-09-27

Abstract:Preeclampsia is a unique multisystem progressive disease during pregnancy, which seriously endangers the health of pregnant women and fetuses. In clinical practice, aspirin is recommended for the prevention of preeclampsia, but the mechanism by which aspirin prevents preeclampsia has not yet been revealed. This report comprehensively evaluates the effects of aspirin on the expression and activity of placental metabolic enzymes and transporters. We found that after aspirin administration, only the expression of organic anion transporter 4 (OAT4) in the placenta showed a significant increase at both mRNA and protein levels, consistent with the results in JAR cells. Meanwhile, studies on the metabolic enzyme activity in the placenta showed a high upregulation of CYP19A1 activity. Subsequently, significant increases in endogenous substrates of OAT4 and CYP19A1 (dehydroepiandrosterone sulfate (DHEAS) and androstenedione) as well as estrone were detected in placental tissue. In summary, aspirin enhances the transport of DHEAS through OAT4 and promotes the metabolism of androstenedione through CYP19A1, thereby increasing estrogen levels in the placenta. This may be the mechanism by which aspirin prevents preeclampsia and maintains pregnancy by regulating the metabolism and transport function of the placenta.
Aspirin protects human trophoblast HTR-8/SVneo cells from H2O2-Induced oxidative stress via NADPH/ROS pathway

Xin Guo,Dinareer Dilidaxi,Lihua Li,Chunyan Wang,Xiaoqing Ma,Fei Sang,Guizhen Pei,Wei Li

DOI: https://doi.org/10.1016/j.placenta.2023.11.008

IF: 3.287

Placenta

Abstract:Introduction: Pre-eclampsia (PE) is a pregnancy complication that can lead to maternal, fetal, and neonatal deaths in clinical practice. Accumulation of trophoblastic reactive oxygen species (ROS), which could result in oxidative stress and cell apoptosis, is considered to play an important role in PE pathology. It has been reported that aspirin has a positive effect on PE treatment in high-risk pregnant women. Methods: In vitro, extravillous trophoblast cell line (HTR-8/SVneo) were treated with hydrogen peroxide (H2O2, 150 μM) after the presence of aspirin (90 and 120 μM) with or without GKT137831 (a Nox4 inhibitor, 20 μM). A series of experiments including CCK-8 assays, flow cytometry, biochemical testing, and Western Blotting etc. verified the protective effects and potential mechanisms of aspirin against oxidative stress-induced damage in PE. Results: Our results demonstrated that H2O2 induces oxidative stress and apoptosis in HTR8/SVneo cells. However, aspirin pretreatment rescue cell viability and reduce LDH activity of HTR-8/SVneo cells. Aspirin can suppress the ROS overproduction and MDA level while increase SOD content and CAT activity. In addition, aspirin pretreatment significantly alleviated cell apoptosis and suppressed the expression of Nox4 and its subunits (p22phox and p47phox) at protein and mRNA levels. The above results were more obvious after the combination of aspirin with GKT137831. Discussion: This study demonstrated that aspirin protects human trophoblasts against H2O2-induced oxidative stress and cell apoptosis via suppressing NADPH/ROS pathway. These findings provide novel insights for the application of aspirin as a protective and curative agent against PE.
Echinatin Inhibits Oxidative Stress and Inflammatory Processes in Trophoblast Cells by Inhibiting TLR4‐MyD88‐NF‐κB Pathway in Preeclampsia

Xiangyun Deng,Hu Chen,Yang Zhang,Fengmei Xu,Qian Zhou

DOI: https://doi.org/10.1155/2024/2296727

2024-06-04

Clinical Pharmacology & Therapeutics

Abstract:Background. Preeclampsia (PE) is a common obstetric disorder hallmarked by impaired trophoblast invasion and a skew toward an inflammatory immune response. Echinatin, a flavonoid with established anti‐inflammatory, antioxidant, and anticancer activities, may offer therapeutic benefits in PE. Our study aimed to investigate the effect of echinatin on preeclampsia in vitro and in vivo and to reveal the potential molecular mechanism of its action. Methods. Eighteen adult female Sprague Dawley rats were randomized into three experimental groups: a PE model group, a PE + echinatin treatment group, and a PE + echinatin treatment group with TLR4 overexpression. Placental tissue CK7 expression was assessed by immunohistochemistry. TUNEL immunofluorescence staining quantified placental cell apoptosis. Cell viability, proliferation, and migration were evaluated using cell counting kit‐8, EdU incorporation, and Transwell assays, respectively. Oxidative stress parameters of malondialdehyde, superoxide dismutase, and glutathione peroxidase were measured. Flow cytometry determined cell apoptosis and intracellular reactive oxygen species (ROS) levels. Western blotting evaluated the expression of proteins related to the TLR4‐MyD88‐NF‐κB signaling pathway, and the concentrations of TNF‐α, IL‐6, and IL‐18 were measured with ELISA kits. Results. Echinatin mitigated placental damage, reduced apoptosis, and increased CK7 expression. It significantly enhanced HTR‐8/SVneo cell viability and migration. Echinatin also counteracted H2O2‐induced ROS production and cell death in HTR‐8/SVneo cells. Moreover, it inhibited the expression of proteins within the TLR4‐MyD88‐NF‐κB signaling cascade. Overexpression of TLR4 negated echinatin's protective effects. Conclusion. Echinatin exerts protective effects against oxidative stress and inflammation in PE by targeting the TLR4‐MyD88‐NF‐κB pathway, suggesting its therapeutic potential for the management of preeclampsia.

pharmacology & pharmacy

Open versus laparoscopic appendicectomy

Aspirin Inhibits Fibronectin Expression and Reverses Fibronectin-Mediated Cell Invasiveness by Activating Akt Signaling in Preeclampsia

Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia.

Aspirin reduces sFlt-1 mediated apoptosis of trophoblast cells in preeclampsia.

A conservative orthodontic-prosthetic approach for a difficult clinical situation: a case report.

The Intervention Effect of Aspirin on a Lipopolysaccharide-Induced Preeclampsia-Like Mouse Model by Inhibiting the Nuclear Factor-Κb Pathway†

Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rat by inhibiting the pro-inflammatory pathway.

An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts

Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues.

Combined apocyanin and aspirin treatment activates the PI3K/Nrf2/HO-1 signaling pathway and ameliorates preeclampsia symptoms in rats

Protective Effects of Aspirin Supplemented With Quercetin in L-NAME-Induced Preeclampsia-Like Rats

Mycoplasma Pulmonis and Lymphoma in Bioassays

Vascular Endothelial Growth Factor Attenuates N Omega-Nitro-L-Arginine Methyl Ester-Induced Preeclampsia-Like Manifestations In Rats

Low-Dose Aspirin Reduces Hypoxia-Induced Sflt1 Release Via The Jnk/Ap-1 Pathway In Human Trophoblast And Endothelial Cells

[Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Effect of Vascular Endothelial Growth Factor on Pre-Eclampsia in Pregnant Rats

Low-dose aspirin prevents LPS-induced preeclampsia-like phenotype via AQP-1 and the MAPK/ERK 1/2 pathway

Aspirin increases estrogen levels in the placenta to prevent preeclampsia by regulating placental metabolism and transport function

Aspirin protects human trophoblast HTR-8/SVneo cells from H2O2-Induced oxidative stress via NADPH/ROS pathway

Echinatin Inhibits Oxidative Stress and Inflammatory Processes in Trophoblast Cells by Inhibiting TLR4‐MyD88‐NF‐κB Pathway in Preeclampsia